Nippon Pharmaceuticals to Issue IPO, Appoints Nabil Investment Banking as Issue Manager
Summary
Nippon Pharmaceuticals Limited is preparing to launch its initial public offering after securing regulatory approvals and appointing Nabil Investment Banking Limited as issue and sales manager. The company says it markets more than 60 medicines across multiple therapeutic segments.
Key Points
- Nippon Pharmaceuticals Limited is preparing to issue an IPO to the general public after receiving regulatory approvals.
- The company appointed Nabil Investment Banking Limited as the issue and sales manager for the offering.
- An agreement was signed by Managing Director Mantu Ghimire and Nabil Investment Banking CEO Manish Narayan Joshi.
- Nippon Pharmaceuticals says it manufactures and markets more than 60 products, including tablets, capsules, ointments, creams and syrups.
